Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Electronic Hard Copy In Vitro Diagnostic Companies Analysis Espicom Business Intelligence Ltd, Sep 2007, Pages: 166   Description     Table of Contents     Companies Mentioned        Enquire before Buying    Send to a Friend   This new report from provides an evaluation of the products, alliances and performance of over 30 leading global players. Evaluation of the products, alliances and performance of over 30 leading global players. HUGE POTENTIAL The global market for in vitro diagnostics (IVD) in 2007 is estimated to be US$34 billion and we expect growth to be around 9% annually. Although in vitro diagnostics influence more than 60% of clinical decisions, IVD sales represent only a small proportion of total healthcare expenditures; in 2005 IVD sales in Europe totalled less that 2% of total healthcare expenditure. However, clinicians are under increasing pressure for better clinical outcomes and to control cost through efficient disease management. The early detection and treatment of long-term conditions is critical, and modern, fast and effective diagnostics are essential to meeting these aims. INNOVATION IS DRIVING CHANGE For example, molecular diagnostics is the fastest growing segment of clinical diagnostics with a growth rate of around 10-15% and is estimated to be worth approximately US$2.4 billion. By detecting DNA and RNA sequences characteristic of bacteria, viruses or cells, molecular diagnostics has applications in a wide variety of disorders including infectious diseases, cancer and cardiovascular. Molecular diagnostic testing is often complex and usually carried out in a lab environment. The trend and challenge is to create testing products which provide fast and accurate results in a clinical setting. This is a competitively hot area with Beckman Coulter, Becton Dickinson, Siemens, bioMérieux, Roche and Gen-Probe all involved. Customers who bought this item also bought High Growth Diagnostics: Technology and Market Analyses Clinical Chemistry Analyzers and Reagents - Global Strategic Business Report Molecular Diagnostics: Transforming Pharmaceuticals, Impacting New Markets Forest Laboratories: Pipeline - Products - Performance - Potential Molecular Diagnostics Markets Bristol-Myers Squibb: Pipeline - Products - Performance - Potential Clinical Laboratory Testing Volume 1: Reagents and Instruments Eli Lilly - Pipeline - Products - Performance - Potential

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster